Clinical Trials Logo

Clinical Trial Summary

The dissemination of individual tumor cells is a common phenomenon in solid cancers. Detection of tumor cells in peripheral blood circulating tumor cells (CTC) in nonmetastatic situation is of high prognostic significance.

The objective of our study was to detect circulating tumor cells in two different method in patient with head and neck squamous cell carcinoma .


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02892786
Study type Interventional
Source Institut de Cancérologie de Lorraine
Contact
Status Completed
Phase N/A
Start date December 8, 2010
Completion date April 2018

See also
  Status Clinical Trial Phase
Active, not recruiting NCT02572869 - Functional and Aesthetic Outcomes After Mandible Reconstruction With Fibula Osteomyocutaneous Free Flaps N/A
Active, not recruiting NCT02823574 - Study of Nivolumab in Combination With Ipilimumab Versus Nivolumab in Combination With Ipilimumab Placebo in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Phase 2
Withdrawn NCT03238638 - A Study of Epacadostat + Pembrolizumab in Head and Neck Cancer Patients, Who Failed Prior PD-1/PD-L1 Therapy Phase 2
Not yet recruiting NCT03266276 - Assessing Impact of CCO's PSO & PC Pathway in Ambulatory HNC Clinics N/A
Recruiting NCT02903914 - Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors Phase 1/Phase 2
Recruiting NCT03302676 - The Use of Chewing Gum for Xerostomia and Hyposalivation After Radiotherapy for Oral and Oropharyngeal Tumors Phase 3
Not yet recruiting NCT02875795 - Carcinologic Speech Severity Index N/A
Recruiting NCT02546895 - Prospective Registration of Head and Neck Cancer
Recruiting NCT02308072 - Phase I Study of Olaparib Combined With Cisplatin-based Chemoradiotherapy to Treat Locally Advanced Head and Neck Cancer Phase 1
Recruiting NCT02554968 - Reliability and Validity of Patient Reported Outcome Measures in Head and Neck Cancer N/A
Active, not recruiting NCT02526017 - Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers Phase 1
Recruiting NCT02017509 - Immunoscore in Rectal Cancer N/A
Recruiting NCT02489084 - Predictive Models for Radiation-induced Side Effects in Head and Neck Cancer Based on Single Nucleotide Polymorphisms (SNP) N/A
Active, not recruiting NCT01895829 - Ferumoxytol - Iron Oxide Nanoparticle Magnetic Resonance Dynamic Contrast Enhanced MRI Early Phase 1
Completed NCT02038114 - The Impact of a Patient Education Intervention for Ambulatory Oncology Patients N/A
Completed NCT01955239 - Parotid-gland Stem-cell Sparing Intensity-modulated Radiotherapy N/A
Completed NCT01952821 - Validity and Reliability of Outcome Measures in Patients With Cancer of the Head and Neck N/A
Completed NCT02921984 - Concurrent Chemotherapy Based on Genetic Testing in Patients With High-Risk Salivary Gland Tumors Phase 1
Recruiting NCT01936376 - A Prospective Observational Study to Evaluate Acute Kidney Injury Biomarkers In Patients Receiving First Cycle of Cisplatin Chemotherapy for Head and Neck Cancers N/A
Withdrawn NCT01506427 - A Study of [F-18]HX4 (PET Imaging)Evaluated in Head and Neck Cancer Patients Phase 1/Phase 2